Process for garenoxacin mesylate

作者: Pramod A Dhebade , Shekhar Ashok Deshmukh , Changdev Namdev Raut

DOI:

关键词: PharmacologyNuclear chemistryPowder diffractionGARENOXACIN MESYLATEMaterials science

摘要: The present invention provides garenoxacin mesylate crystalline form characterized by an X-ray powder diffraction pattern with peaks at about 13.77, 20.54, 21.50, 21.77, 22.12 and 23.90 ± 0.2 °θ.

参考文章(7)
Nitya Anand, William A. Remers, Synthetic Antibacterial Agents Burger's Medicinal Chemistry and Drug Discovery. pp. 481- 562 ,(2010) , 10.1002/0471266949.BMC086.PUB2
Junichi Mitsuyama, Kazuya Hayashi, Tetsumi Yamakawa, Hiroyo Kawafuchi, Tokunori Kito, Hiroshi Kuroda, Quinolonecarboxylic acid derivatives or salts thereof ,(1997)
Mao Yaqin, The Synthesis of Garenoxacin The Chinese Journal of Modern Applied Pharmacy. ,(2009)
Tamotsu Takamatsu, Shoichi Hamamoto, Kenji Yonezawa, Taro Kiyoto, Kazuko Takaoka, Minako Yotsuji, Hirohiko Yamamoto, Kyoko Taya, Hiroko Matsukura, Hironori Kotsubo, Katsuji Ojima, Minoru Yamada, Kazuya Hayashi, Processes for producing 7-isoindolinequinolonecarboxylic derivatives and intermediates therefor, salts of 7-isoindolinequinolonecarboxylic acids, hydrates thereof, and composition containing the same as active ingredient ,(1998)
Keidai Kawabuchi, 啓代 川淵, Production of quinolonecarboxylic acid and its intermediate ,(1999)